Showing 1 posts of 1 posts found.
Actelion says it is ready to launch Uptravi, its drug for pulmonary arterial hypertension in the US in January, after …
Functional lung imaging offers new possibilities for respiratory care
Five Facts about cardiovascular disease
Data integrity: the keystone for AI adoption, patient safety and organisational reputation
Artificial hearts: a century of innovation
Product value to pathway impact: What the CVD Modern Service Framework means for pharma